These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7626486)

  • 1. Antiestrogens: mechanisms and actions in target cells.
    Katzenellenbogen BS; Montano MM; Le Goff P; Schodin DJ; Kraus WL; Bhardwaj B; Fujimoto N
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):387-93. PubMed ID: 7626486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors: bioactivities and interactions with cell signaling pathways.
    Katzenellenbogen BS
    Biol Reprod; 1996 Feb; 54(2):287-93. PubMed ID: 8788178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways.
    Katzenellenbogen BS
    J Soc Gynecol Investig; 2000; 7(1 Suppl):S33-7. PubMed ID: 10732327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.
    McInerney EM; Katzenellenbogen BS
    J Biol Chem; 1996 Sep; 271(39):24172-8. PubMed ID: 8798658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
    Fujimoto N; Katzenellenbogen BS
    Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
    Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
    Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK
    Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes.
    Liu S; Han SJ; Smith CL
    Mol Pharmacol; 2013 May; 83(5):1066-77. PubMed ID: 23462505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
    Montano MM; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
    Eng FC; Lee HS; Ferrara J; Willson TM; White JH
    Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.
    McDonnell DP; Clemm DL; Hermann T; Goldman ME; Pike JW
    Mol Endocrinol; 1995 Jun; 9(6):659-69. PubMed ID: 8592512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of "pure" antiestrogens in inhibiting estrogen receptor action.
    Parker MG
    Breast Cancer Res Treat; 1993; 26(2):131-7. PubMed ID: 8219250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.